ARHGEF9 Inhibitors
The chemical class known as ARHGEF9 inhibitors comprises a carefully curated selection of compounds designed to modulate the activity of ARHGEF9 by targeting the Rho GTPase signaling pathways. These inhibitors offer precise control over the molecular mechanisms that govern ARHGEF9 activity, presenting a valuable toolkit for researchers investigating the intricate roles of ARHGEF9 in cellular processes. EHop-016, NSC 23766, ML141, AZA1, SecinH3, LFM-A13, CASIN, ITX3, Rhosin, ITX1, NSC 23766 trifluoroacetate, and Rhosin hydrochloride each provide a unique approach to influencing ARHGEF9 through their specific interactions with the Rho GTPase family. EHop-016 and NSC 23766 disrupt Rac GTPase activation, indirectly modulating ARHGEF9, while ML141 selectively inhibits Cdc42, a key substrate of ARHGEF9.
Additionally, compounds like AZA1, SecinH3, Rhosin, and ITX1 target RhoA, influencing ARHGEF9 through the regulation of this essential GTPase. LFM-A13 and ITX3 broaden the scope by targeting Lyn and Fyn kinases, providing a means to indirectly modulate ARHGEF9 implicated in Lyn and Fyn-related signaling pathways. CASIN specifically inhibits Cdc42 GTPase, offering a focused approach to ARHGEF9 modulation. In conclusion, the ARHGEF9 inhibitors chemical class empowers researchers with a comprehensive set of tools to explore the intricate web of Rho GTPase signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
EHop-016 is a specific inhibitor of Rac GTPases, targeting their activation. By disrupting Rac signaling, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for Rac. The compound's specificity for Rac activation ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 is a selective inhibitor of Rac1-GEF interaction. By inhibiting Rac1 activation, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for Rac1. The compound's specificity for Rac1-GEF interaction ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective Cdc42 inhibitor. By targeting Cdc42, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for Cdc42. The compound's specificity for Cdc42 inhibition ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
AZA1 | 1071098-42-4 | sc-507497 | 10 mg | $600.00 | ||
AZA1 is an inhibitor of the Rho family GTPases. By disrupting Rho GTPase signaling, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for Rho GTPases. The compound's specificity for Rho GTPases ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 is a specific inhibitor of Rho GTPases by interfering with their prenylation. By disrupting Rho GTPase signaling, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for Rho GTPases. The compound's specificity for Rho GTPases ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
LFM-A13 | 62004-35-7 | sc-203623 sc-203623A | 10 mg 50 mg | $119.00 $670.00 | ||
LFM-A13 is a small molecule inhibitor of Lyn and Fyn kinases. By targeting Lyn and Fyn, it indirectly modulates ARHGEF9, as ARHGEF9 is implicated in signaling pathways involving Lyn and Fyn. The compound's specificity for Lyn and Fyn kinases ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
CASIN is a selective Cdc42 GTPase inhibitor. By targeting Cdc42, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for Cdc42. The compound's specificity for Cdc42 inhibition ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
ITX3 is a selective inhibitor of TrioN, a guanine nucleotide exchange factor for RhoA, Rac1, and Cdc42. By disrupting TrioN activity, it indirectly modulates ARHGEF9, as ARHGEF9 is implicated in signaling pathways involving RhoA, Rac1, and Cdc42. The compound's specificity for TrioN ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin hydrochloride is a selective RhoA inhibitor. By targeting RhoA, it indirectly modulates ARHGEF9, as ARHGEF9 is a guanine nucleotide exchange factor for RhoA. The compound's specificity for RhoA inhibition ensures precise control over the pathway, subsequently influencing ARHGEF9 activity. | ||||||